Onset and pre-onset studies to define the Huntington's disease natural history

Brain Research Bulletin

Volumn 56, Issue 3-4, 2001, Pages 233-238

  Squitieri, F ^a   Cannella, M ^a   Giallonardo, P ^a   Maglione, V ^a   Mariotti, C ^b   Hayden, M R ^c  

^a IRCCS NEUROMED   (Italy)

^b DEPARTMENT OF NEUROSURGERY   (Italy)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Clinical history; Onset symptoms; Predictive diagnosis

Indexed keywords

CONFERENCE PAPER; DNA POLYMORPHISM; GENE MUTATION; HUMAN; HUNTINGTON CHOREA; MEIOSIS; MENTAL DISEASE; NERVE PROJECTION; ONSET AGE; PHENOTYPE; PREDICTION; PRIORITY JOURNAL; SYMPTOM; TRANSGENIC ANIMAL; TRINUCLEOTIDE REPEAT;

AGE OF ONSET; DISEASE PROGRESSION; HUMANS; HUNTINGTON DISEASE; PREDICTIVE VALUE OF TESTS; TRINUCLEOTIDE REPEAT EXPANSION;

EID: 0035504484     PISSN: 03619230     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0361-9230(01)00648-7     Document Type: Conference Paper

References (66)

1. Preferential loss of striato-external pallidal projection neurons in presymptomatic Huntington's disease
2. The relationship between trinucleotide (CAG) repeat length and clinical features of Huntington's disease
3. Striatal glucose metabolism and dopamine D2 receptor binding in asymptomatic gene carriers and patients with Huntington's disease
4. Repeats may not be everything in anticipation
5. Reduced basal ganglia volume associated with the gene for Huntington's disease in asymptomatic at-risk person
6. Proceed with care; Direct predictive testing for Huntington disease
7. The likelihood of being affected with Huntington disease by a particular age, for a specific CAG size
8. Environmental stimulation survival in mice transgenic for exon 1 of the Huntington's disease gene
9. Loss of normal huntingtin function; New developments in Huntington's disease research
10. Evidence for a mechanism predisposing to intergenerational CAG repeat instability in spinocerebellar ataxia type I
11. Analysis of the 5′ upstream sequence of the Huntington' disease (HD) gene shows six new alleles which are unrelated to the age at onset of HD
12. Early cognitive and motor symptoms in identified carriers of the gene for Huntington disease
13. Subtle involuntary movements are not reliable indicators of incipient Huntington's disease
14. Onset symptoms in 510 patients with Huntington's disease
15. Trinucleotide repeat length instability and age of onset in Huntington's disease
16. Chromosomal imprinting and the parent transmission specific variation in expressivity of Huntington's disease
17. Huntington's disease in Maryland; Clinical aspect of racial variation
18. Differences in duration of Huntington's disease based on age at onset
19. Analysis of (CAG)n size heterogeneity in somatic and sperm cell DNA from intermediate and expanded Huntington disease gene carriers
20. Molecular analysis of new mutations for Huntington's disease; Intermediate alleles and sex of origin effects
21. Are cognitive changes the first symptoms of Huntington's disease? A study of gene carriers
22. YAC mouse model for Huntington's disease with full-length mutant huntingtin, cytoplasmic toxicity, and selective striatal neurodegeneration
23. Dentatorubral-pallidoluysian atrophy; Clinical features are closely related to unstable expansion of trinucleotide (CAG) repeat
24. Guidelines for the molecular genetics predictive test in Huntington's disease
25. Age of onset in Huntington disease; Sex specific influence of apolipoprotein E genotype and normal CAG repeat length
26. DNA analysis in hereditary dentatorubral-pallidoluysian atrophy; Correlation between CAG repeat length and phenotypic variation and the molecular basis of anticipation
27. Sex-dependent mechanisms for expansion and contraction of the CAG repeat on affected Huntington disease chromosomes
28. A worldwide study of the Huntington's disease mutation
29. Molecular analysis of late onset Huntington's disease
30. Cryptic and polar variation of the fragile X repeat could result in predisposing normal alleles
31. Evidence for specific cognitive deficits in preclinical Huntington's disease
32. Single sperm analysis of the trinucleotide repeats in the Huntington's disease gene; Quantification of the mutation frequency spectrum
33. Dystonia-predominant adult-onset Huntington disease
34. Familial psychiatric presentation of Huntington's disease
35. Evidence for the GluR6 gene associated with younger onset age of Huntington's disease
36. Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice
37. De novo expansion of a (CAG)n repeat in sporadic Huntington's disease
38. Analysis of trinucleotide repeat expansion in Italian families affected with Huntington disease
39. Apolipoprotein E and presenilin-1 genotypes in Huntington's disease
40. Huntington's disease in Venezuela; 7 years of follow-up on symptomatic and asymptomatic individuals
41. Knowledge, attitude, and the decision to be tested for Huntington's disease
42. Anticipation and instability of IT-15 (CAG)n repeats in parent-offspring pairs with Huntington disease
43. Behavioural abnormalities and selective neuronal loss in HD transgenic mice expressing full-length HD cDNA
44. Anticipation in Huntington's disease is inherited through the male line, but may originate in the female
45. Wild-type huntingtin protects from apoptosis upstream of caspase-3
46. Genotype at the GluR6 kainate receptor locus are associated with variation in the age of onset of Huntington disease
47. Mutational bias provides a model for the evolution of Huntington's disease and predicts a general increase in disease prevalence
48. Phenotypic characterization of individuals with 30-40 CAG repeats in the Huntington disease (HD) gene reveals HD cases with 36 repeats and apparently elderly individuals with 36-39 repeats
49. Huntington's disease CAG expansion at the murine Hdf locus is unstable and associated with behavioural abnormalities in mice
50. Relationship between trinucleotide repeat expansion and phenotypic variation in Huntington's disease
51. DNA haplotype analysis of Huntington's disease reveals clues to the origins and mechanisms of CAG expansion and reason for geographic variations of prevalence
52. Atypical movement disorders in the early stages of Huntington's disease; Clinical and genetic analysis
53. Family and molecular data for a fine analysis of age at onset in Huntington disease
54. Mutation in Huntington's chorea
55. Somatic mosaicism in sperm is associated with intergenerational (CAG)n changes in Huntington disease
56. Molecular analysis of juvenile Huntington disease; The major influence on (CAG)n repeat length is the sex of the affected parent
57. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes
58. Instability of CAG repeats in Huntington's disease; Relationship to parental transmission and age of onset
59. Familial aggregation of psychotic symptoms in Huntington's disease
60. Stability of the Huntington disease (CAG)n repeat in a late onset form occurring on the Island of Crete
61. Genetic polymorphisms adjacent to the CAG repeat influence clinical features at onset in Huntington's disease
62. Striatal D1 and D2 dopamine receptor loss in asymptomatic carriers of Huntington's disease
63. Reversal of neuropathology and motor dysfunction in a conditional model of Huntington's disease
64. Psychiatric symptoms do not correlate with cognitive decline, motor symptoms, or CAG repeat length in Huntington's disease